Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Keel Infrastructure Corp. Common Stock (KEEL) vs Dr. Reddy's Laboratories Ltd Common Stock (RDY) Price & Performance

Keel Infrastructure Corp. Common StockTrade
Dr. Reddy's Laboratories Ltd Common StockTrade

Price performance (Past 24H)

Key statistics

Keel Infrastructure Corp. Common Stock vs Dr. Reddy's Laboratories Ltd Common Stock — how do they compare? Keel Infrastructure Corp. Common Stock trades at $2.44 (market cap $1.77B), while Dr. Reddy's Laboratories Ltd Common Stock trades at $12.75 (market cap $10.78B). The key difference: Dr. Reddy's Laboratories Ltd Common Stock is far larger — about 6.1× Keel Infrastructure Corp. Common Stock's market cap, and Dr. Reddy's Laboratories Ltd Common Stock pays a 0.65% dividend while Keel Infrastructure Corp. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Keel Infrastructure Corp. Common Stock for 3 Days and Dr. Reddy's Laboratories Ltd Common Stock for 0 Days on average.

KEELRDY
Market Cap
$1.77B$10.78B
Volume
34,111,6502,724,343
Sector
TechnologyHealth
52-Week High
$6.66$15.38
52-Week Low
$1.71$11.38
Typical Hold Time
3 Days0 Days
Enterprise Value
$2.09B$10.68B
Dividend Yield
—0.65%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Keel Infrastructure Corp. Common Stock

KEEL trades at $2.87, down 2.71% on the day, reflecting a bearish technical trend amid weak financial performance. The company reported a net loss of $208.51M on $229.28M revenue in 2025, with negative profit margins and cash flow from operations. Despite this, analyst consensus is unanimously bullish with a $6.25 price target, citing progress in its HPC and AI data center strategy, including a recent partnership with PowerSecure for its Moses Lake campus.

The outlook hinges on successful execution of its data center pivot, offering significant upside if leasing targets are met, but high execution risk and persistent losses pose substantial threats to shareholder value. Liquidity remains supported by financing activities, yet profitability challenges and competitive pressures require careful monitoring.

Dr. Reddy's Laboratories Ltd Common Stock

No Aura AI signal available yet.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

KEEL
100% Buy0% Sell
Avg holding period · 3 Days
RDY
100% Buy0% Sell
Avg holding period · 0 Days

About Keel Infrastructure Corp. Common Stock

Keel Infrastructure develops and owns digital and energy infrastructure for high-performance computing workloads. Its assets include data centers and power infrastructure that support AI computing.

Read more on KEEL →

About Dr. Reddy's Laboratories Ltd Common Stock

Dr. Reddy's Laboratories Ltd. develops and manufactures generic medicines, active pharmaceutical ingredients (APIs), biosimilars, and over-the-counter (OTC) products, headquartered in Hyderabad, India, with therapeutic focus areas spanning gastrointestinal, cardiovascular, oncology, and dermatology.

Read more on RDY →